Robert Dillman
Institution Name:
Total Awards:
1
Award Value:
$3,000,000
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Caladrius Biosciences | Tumor stem cell-targeted immunotherapy for metastatic melanoma –a randomized phase 3 clinical trial. | $3,000,000 |
| Total: $3,000,000.00 |